NASDAQ:EXAC - Exactech Stock Price, Price Target & More

$49.25 0.00 (0.00 %)
(As of 04/26/2018 09:30 AM ET)
Previous Close$49.25
Today's Range$49.25 - $49.30
52-Week Range$23.75 - $50.95
Volume256,300 shs
Average Volume182,742 shs
Market Capitalization$707.53 million
P/E RatioN/A
Dividend YieldN/A
Beta0.9

About Exactech (NASDAQ:EXAC)

Exactech logoExactech, Inc. develops, manufactures, markets, distributes and sells orthopedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians. The Company's segments include knee, hip, biologics and spine, extremity and other products. Its other products segment includes miscellaneous sales categories, such as bone cement, instrument rental fees, shipping charges and other product lines. The Company distributes joint replacement systems, including knee, hip, spine and extremity implant systems, and biologic products and services and bone cement materials used in orthopedic surgery and dental procedures. The Exactech Knee System provides solutions for partial, primary and revision total knee arthroplasty. Its hip solutions address the continuum of hip arthroplasty. It manufactures and distributes various products and services designed for the healing and regeneration of bone and soft tissue, including products, which contain human allograft.

Receive EXAC News and Ratings via Email

Sign-up to receive the latest news and ratings for EXAC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryHealth Care Equipment
SectorN/A
SymbolNASDAQ:EXAC
CUSIP30064E10
Phone+1-352-3771140

Debt

Debt-to-Equity Ratio0.06%
Current Ratio4.08%
Quick Ratio2.09%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E Ratio37.88
P/E Growth3.66

Sales & Book Value

Annual Sales$257.57 million
Price / Sales2.76
Cash Flow$2.5413 per share
Price / Cash19.38
Book Value$16.51 per share
Price / Book2.98

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$160,000.00
Net Margins4.72%
Return on Equity4.62%
Return on Assets3.82%

Miscellaneous

Employees733
Outstanding Shares14,420,000

How to Become a New Pot Stock Millionaire

Exactech (NASDAQ:EXAC) Frequently Asked Questions

What is Exactech's stock symbol?

Exactech trades on the NASDAQ under the ticker symbol "EXAC."

How were Exactech's earnings last quarter?

Exactech, Inc. (NASDAQ:EXAC) issued its earnings results on Monday, October, 30th. The medical equipment provider reported $0.20 earnings per share for the quarter, missing the consensus estimate of $0.23 by $0.03. The medical equipment provider earned $61.40 million during the quarter, compared to the consensus estimate of $61.78 million. Exactech had a return on equity of 4.62% and a net margin of 4.72%. View Exactech's Earnings History.

What price target have analysts set for EXAC?

3 brokerages have issued twelve-month target prices for Exactech's stock. Their forecasts range from $49.00 to $49.00. On average, they anticipate Exactech's stock price to reach $49.00 in the next twelve months. View Analyst Ratings for Exactech.

Who are Exactech's key executives?

Exactech's management team includes the folowing people:
  • R. William Petty M.D., Executive Chairman of the Board (Age 74)
  • David W. Petty, Chief Executive Officer, President and Director (Age 50)
  • Joel C. Phillips CPA, Chief Financial Officer, Executive Vice President, Treasurer (Age 49)
  • Bruce E. Thompson, Senior Vice President , General manager- Biologics and Spine Division (Age 59)
  • Gary J. Miller Ph.D., Executive Vice President - Research and Development (Age 69)
  • Donna M. Edwards, Vice President, Legal and General Counsel (Age 44)
  • Betty A. Petty, Vice President - Administration, Corporate Secretary (Age 74)
  • James G. Binch, Independent Director (Age 69)
  • W. Andrew Krusen Jr., Independent Director (Age 68)
  • William B. Locander Ph.D., Independent Director (Age 73)

Has Exactech been receiving favorable news coverage?

Media coverage about EXAC stock has been trending somewhat positive recently, according to Accern Sentiment Analysis. The research firm identifies negative and positive press coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Exactech earned a coverage optimism score of 0.15 on Accern's scale. They also gave news coverage about the medical equipment provider an impact score of 45.34 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the next several days.

How do I buy shares of Exactech?

Shares of EXAC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Exactech's stock price today?

One share of EXAC stock can currently be purchased for approximately $49.25.

How big of a company is Exactech?

Exactech has a market capitalization of $707.53 million and generates $257.57 million in revenue each year. Exactech employs 733 workers across the globe.

How can I contact Exactech?

Exactech's mailing address is 2320 NW 66th Ct, GAINESVILLE, FL 32653-1630, United States. The medical equipment provider can be reached via phone at +1-352-3771140 or via email at [email protected]


MarketBeat Community Rating for Exactech (EXAC)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  126 (Vote Outperform)
Underperform Votes:  166 (Vote Underperform)
Total Votes:  292
MarketBeat's community ratings are surveys of what our community members think about Exactech and other stocks. Vote "Outperform" if you believe EXAC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EXAC will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Exactech (NASDAQ:EXAC) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
3 Wall Street analysts have issued ratings and price targets for Exactech in the last 12 months. Their average twelve-month price target is $49.00, suggesting that the stock has a possible downside of 0.51%. The high price target for EXAC is $49.00 and the low price target for EXAC is $49.00. There are currently 3 hold ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.002.002.002.00
Ratings Breakdown: 0 Sell Rating(s)
3 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $49.00$49.00$49.00$42.00
Price Target Upside: 0.51% downside3.07% downside3.07% downside0.36% upside

Exactech (NASDAQ:EXAC) Consensus Price Target History

Price Target History for Exactech (NASDAQ:EXAC)

Exactech (NASDAQ:EXAC) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/7/2017Robert W. BairdReiterated RatingHold$49.00LowView Rating Details
10/24/2017GabelliDowngradeBuy -> HoldN/AView Rating Details
10/23/2017SidotiDowngradeBuy -> NeutralN/AView Rating Details
(Data available from 4/26/2016 forward)

Earnings

Exactech (NASDAQ:EXAC) Earnings History and Estimates Chart

Earnings by Quarter for Exactech (NASDAQ:EXAC)

Exactech (NASDAQ:EXAC) Earnings Estimates

Current Year EPS Consensus Estimate: $1.3 EPS
Next Year EPS Consensus Estimate: $1.4 EPS

Exactech (NASDAQ EXAC) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/30/2017Q3 2017$0.23$0.20$61.78 million$61.40 millionViewN/AView Earnings Details
7/27/2017Q2 2017$0.33$0.33$67.75 million$67.30 millionViewN/AView Earnings Details
4/25/2017Q1 2017$0.31$0.34$67.05 million$69.48 millionViewN/AView Earnings Details
2/21/2017Q416$0.32$0.34$66.00 million$66.20 millionViewListenView Earnings Details
10/31/2016Q316$0.22$0.22$58.69 million$59.90 millionViewN/AView Earnings Details
8/1/2016Q216$0.30$0.31$64.18 million$66.10 millionViewN/AView Earnings Details
4/26/2016Q116$0.29$0.31$63.63 million$65.30 millionViewN/AView Earnings Details
2/16/2016Q415$0.28$0.29$61.29 million$62.70 millionViewListenView Earnings Details
10/27/2015Q315$0.23$0.20$58.46 million$56.20 millionViewListenView Earnings Details
7/28/2015Q215$0.27$0.26$62.13 million$61.50 millionViewListenView Earnings Details
4/28/2015Q115$0.30$0.29$63.71 million$61.40 millionViewN/AView Earnings Details
2/17/2015Q414$0.33$0.36$63.30 million$63.30 millionViewN/AView Earnings Details
10/21/2014Q314$0.25$0.21$58.60 million$57.90 millionViewN/AView Earnings Details
7/28/2014Q214$0.30$0.30$63.80 million$63.92 millionViewN/AView Earnings Details
4/21/2014Q114$0.29$0.30$63.05 million$63.30 millionViewN/AView Earnings Details
2/19/2014Q413$0.31$0.33$63.20 million$61.60 millionViewN/AView Earnings Details
10/22/2013Q313$0.21$0.23$55.36 million$55.70 millionViewN/AView Earnings Details
7/23/2013Q2 2013$0.25$0.27$58.42 million$60.60 millionViewN/AView Earnings Details
4/23/2013Q1 2013$0.29$0.29$61.63 million$59.30 millionViewN/AView Earnings Details
2/26/2013Q4 2012$0.28$0.29$58.20 million$59.30 millionViewN/AView Earnings Details
10/30/2012Q312$0.17$0.19$50.20 million$51.30 millionViewN/AView Earnings Details
7/31/2012$0.23$0.23ViewN/AView Earnings Details
5/1/2012$0.23$0.25ViewN/AView Earnings Details
2/28/2012$0.25$0.18ViewN/AView Earnings Details
11/1/2011$0.20$0.15ViewN/AView Earnings Details
8/2/2011$0.26$0.28ViewN/AView Earnings Details
5/3/2011$0.27$0.28ViewN/AView Earnings Details
2/28/2011$0.23$0.23ViewN/AView Earnings Details
11/2/2010Q3 2010$0.21$0.12ViewN/AView Earnings Details
8/3/2010Q2 2010$0.24$0.25ViewN/AView Earnings Details
4/27/2010Q1 2010$0.23$0.26ViewN/AView Earnings Details
2/22/2010Q4 2009$0.23$0.25ViewN/AView Earnings Details
10/27/2009Q3 2009$0.18$0.25ViewN/AView Earnings Details
7/28/2009Q2 2009$0.25$0.26ViewN/AView Earnings Details
4/29/2009Q1 2009$0.21$0.26ViewN/AView Earnings Details
2/18/2009Q4 2008$0.21$0.26ViewN/AView Earnings Details
10/28/2008Q3 2008$0.15$0.16ViewN/AView Earnings Details
7/30/2008Q2 2008$0.23$0.24ViewN/AView Earnings Details
4/29/2008Q1 2008$0.20$0.21ViewN/AView Earnings Details
2/28/2008Q4 2007$0.23$0.23ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Exactech (NASDAQ:EXAC) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Exactech (NASDAQ EXAC) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 28.30%
Institutional Ownership Percentage: 61.22%
Insider Trading History for Exactech (NASDAQ:EXAC)
Institutional Ownership by Quarter for Exactech (NASDAQ:EXAC)

Exactech (NASDAQ EXAC) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/8/2017Fern WattsDirectorSell1,013$29.04$29,417.524,727View SEC Filing  
8/4/2017James G BinchDirectorSell747$28.40$21,214.803,554View SEC Filing  
5/31/2017William B LocanderDirectorSell988$30.34$29,975.928,555View SEC Filing  
5/23/2017Joel C PhillipsCFOSell7,610$30.71$233,703.1099,907View SEC Filing  
3/9/2017Fern WattsDirectorSell1,000$24.25$24,250.005,101View SEC Filing  
3/8/2017James G BinchDirectorSell3,588$24.16$86,686.086,850View SEC Filing  
3/1/2017William B LocanderDirectorSell1,823$24.52$44,699.967,801View SEC Filing  
2/24/2017Bruce E ThompsonSVPSell4,906$24.77$121,521.6227,937View SEC Filing  
11/3/2016James G BinchDirectorSell600$22.61$13,566.005,682View SEC Filing  
8/25/2016Fern WattsDirectorSell1,100$27.68$30,448.004,936View SEC Filing  
8/22/2016Bruce E ThompsonSVPSell1,433$27.97$40,081.0125,375View SEC Filing  
8/19/2016David W PettyCEOSell3,550$27.75$98,512.5063,122View SEC Filing  
7/1/2016Joel C PhillipsCFOSell3,000$26.75$80,250.00101,632View SEC Filing  
6/8/2016Gary J MillerEVPSell9,800$25.16$246,568.0030,914View SEC Filing  
6/7/2016Bruce E ThompsonSVPSell2,000$25.07$50,140.0025,647View SEC Filing  
6/3/2016James G BinchDirectorSell600$24.86$14,916.005,585View SEC Filing  
6/2/2016Gary J MillerEVPSell3,381$25.11$84,896.9130,914View SEC Filing  
5/25/2016Gary J MillerEVPSell9,319$25.10$233,906.9030,914View SEC Filing  
5/18/2016Gary J MillerEVPSell9,664$24.37$235,511.6830,914View SEC Filing  
5/9/2016Joel C PhillipsCFOSell3,900$23.13$90,207.00100,632View SEC Filing  
5/5/2016James G BinchDirectorSell1,870$23.00$43,010.005,400View SEC Filing  
5/3/2016Fern WattsDirectorSell2,000$22.76$45,520.006,251View SEC Filing  
4/29/2016Betty A PettyVPSell18,000$22.65$407,700.0070,400View SEC Filing  
4/27/2016Gary J MillerEVPSell9,851$24.06$237,015.0630,914View SEC Filing  
4/26/2016Gary J MillerEVPSell7,985$23.11$184,533.3530,914View SEC Filing  
4/25/2016Gary J MillerEVPSell4,725$23.14$109,336.5030,914View SEC Filing  
3/31/2016Gary J MillerEVPSell7,000$19.95$139,650.0030,914View SEC Filing  
3/10/2016Joel C PhillipsCFOSell2,000$18.58$37,160.00104,226View SEC Filing  
3/8/2016Betty A PettyVPSell15,964$19.06$304,273.8479,627View SEC Filing  
3/7/2016Donna M EdwardsVPSell10,000$18.85$188,500.0019,795View SEC Filing  
3/3/2016Gary J MillerEVPSell7,017$19.23$134,936.9137,914View SEC Filing  
3/3/2016William B LocanderDirectorSell2,435$19.25$46,873.754,866View SEC Filing  
12/10/2015James G BinchDirectorSell1,500$17.03$25,545.007,232View SEC Filing  
12/9/2015Fern WattsDirectorSell1,200$17.32$20,784.006,213View SEC Filing  
12/1/2015Bruce E. ThompsonSVPSell21,904$17.57$384,853.2823,139View SEC Filing  
11/24/2015Bruce E. ThompsonSVPSell900$17.75$15,975.0023,139View SEC Filing  
9/1/2015Bruce E. ThompsonSVPSell2,107$19.45$40,981.1522,780View SEC Filing  
5/28/2015Joel C PhillipsCFOSell5,000$21.76$108,800.00View SEC Filing  
5/20/2015William B LocanderDirectorSell3,350$21.50$72,025.00View SEC Filing  
5/18/2015Fern WattsDirectorSell2,200$21.21$46,662.00View SEC Filing  
5/4/2015Joel C PhillipsCFOSell2,700$21.67$58,509.00View SEC Filing  
3/20/2015Gary J MillerEVPSell32,800$24.95$818,360.00View SEC Filing  
2/24/2015R William PettyChairmanSell45,067$23.08$1,040,146.36View SEC Filing  
2/2/2015Betty A PettyVPSell7,500$20.74$155,550.00View SEC Filing  
1/8/2015Gary J MillerEVPSell4,145$23.17$96,039.65View SEC Filing  
12/3/2014Gary J MillerEVPSell5,000$21.83$109,150.00View SEC Filing  
11/25/2014Betty A PettyMajor ShareholderSell12,500$21.86$273,250.00View SEC Filing  
11/25/2014Bruce E ThompsonSVPSell6,500$22.05$143,325.00View SEC Filing  
10/31/2014Joel C PhillipsCFOSell5,000$21.44$107,200.00View SEC Filing  
9/5/2014R William PettyMajor ShareholderSell25,000$23.68$592,000.00View SEC Filing  
8/25/2014Albert H BursteinDirectorSell8,852$23.73$210,057.96View SEC Filing  
7/1/2014Gary J MillerEVPSell12,392$26.21$324,794.32View SEC Filing  
6/26/2014Gary J MillerEVPSell1,894$25.06$47,463.64View SEC Filing  
6/25/2014Gary J MillerEVPSell16,356$25.33$414,297.48View SEC Filing  
6/10/2014Joel C PhillipsCFOSell5,000$24.77$123,850.00View SEC Filing  
6/5/2014Bruce E ThompsonSVPSell1,667$23.50$39,174.50View SEC Filing  
6/5/2014Joel C PhillipsCFOSell5,000$23.21$116,050.00View SEC Filing  
5/29/2014Bruce E ThompsonSVPSell1,588$23.00$36,524.00View SEC Filing  
5/12/2014David PettyCEOSell10,287$20.99$215,924.1369,253View SEC Filing  
5/8/2014David PettyCEOSell7,976$21.51$171,563.7667,516View SEC Filing  
4/24/2014Bruce ThompsonSVPSell2,412$23.78$57,357.3616,241View SEC Filing  
4/23/2014William LocanderDirectorSell4,500$23.18$104,310.003,724View SEC Filing  
2/28/2014William LocanderDirectorSell1,819$23.16$42,128.048,224View SEC Filing  
12/5/2013R William PettyCEOSell10,000$23.67$236,700.0099,400View SEC Filing  
11/12/2013Bruce ThompsonSVPSell3,079$23.35$71,894.6518,074View SEC Filing  
8/22/2013William LocanderDirectorSell1,521$19.05$28,975.057,640View SEC Filing  
7/15/2013Gary J MillerEVPSell10,250$20.07$205,717.50View SEC Filing  
7/8/2013Gary J MillerEVPSell1,000$20.00$20,000.00View SEC Filing  
6/17/2013Gary J MillerEVPSell8,125$18.98$154,212.50View SEC Filing  
6/5/2013R William PettyCEOSell3,885$18.00$69,930.00View SEC Filing  
6/4/2013R William PettyCEOSell14,257$18.01$256,768.57View SEC Filing  
5/28/2013R William PettyCEOSell20,000$18.21$364,200.00View SEC Filing  
5/22/2013R William PettyCEOSell11,493$18.13$208,368.09View SEC Filing  
5/17/2013R William PettyCEOSell17,472$18.05$315,369.60View SEC Filing  
5/16/2013R William PettyCEOSell22,893$18.22$417,110.46View SEC Filing  
5/9/2013R William PettyCEOSell10,000$18.25$182,500.00View SEC Filing  
5/8/2013David W PettyPresidentSell8,000$18.35$146,800.00View SEC Filing  
12/4/2012R William PettyCEOSell14,048$16.29$228,841.92View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Exactech (NASDAQ EXAC) News Headlines

Source:
DateHeadline
Exactech, Inc. (EXAC) Given Average Recommendation of "Hold" by BrokeragesExactech, Inc. (EXAC) Given Average Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - April 18 at 7:24 PM
Exactech (EXAC) Lowered to Sell at BidaskClubExactech (EXAC) Lowered to Sell at BidaskClub
www.americanbankingnews.com - April 14 at 11:25 PM
Robert W. Baird Analysts Give Exactech (EXAC) a $34.00 Price TargetRobert W. Baird Analysts Give Exactech (EXAC) a $34.00 Price Target
www.americanbankingnews.com - April 7 at 12:48 PM
Exactech (EXAC) Rating Lowered to Hold at GabelliExactech (EXAC) Rating Lowered to Hold at Gabelli
www.americanbankingnews.com - April 5 at 9:00 PM
Exactech Knee Research Honored with Orthopaedic Research Society’s Best Implant Poster AwardExactech Knee Research Honored with Orthopaedic Research Society’s Best Implant Poster Award
www.bizjournals.com - April 3 at 4:29 PM
Comparing Covidien (COV) & Exactech (EXAC)Comparing Covidien (COV) & Exactech (EXAC)
www.americanbankingnews.com - March 28 at 7:18 PM
Exactech (EXAC) vs. Asante Solutions (PUMP) Critical AnalysisExactech (EXAC) vs. Asante Solutions (PUMP) Critical Analysis
www.americanbankingnews.com - March 27 at 1:39 AM
BidaskClub Lowers Exactech (EXAC) to Strong SellBidaskClub Lowers Exactech (EXAC) to Strong Sell
www.americanbankingnews.com - March 26 at 2:30 PM
Exactech (EXAC) Rating Increased to Hold at BidaskClubExactech (EXAC) Rating Increased to Hold at BidaskClub
www.americanbankingnews.com - March 25 at 3:12 PM
63,624 Shares in Exactech, Inc. (EXAC) Purchased by Koch Industries Inc.63,624 Shares in Exactech, Inc. (EXAC) Purchased by Koch Industries Inc.
www.americanbankingnews.com - March 5 at 3:42 PM
Martingale Asset Management L P Sells 30,602 Shares of Exactech, Inc. (EXAC)Martingale Asset Management L P Sells 30,602 Shares of Exactech, Inc. (EXAC)
www.americanbankingnews.com - March 4 at 12:50 PM
Kennedy Capital Management Inc. Takes Position in Exactech, Inc. (EXAC)Kennedy Capital Management Inc. Takes Position in Exactech, Inc. (EXAC)
www.americanbankingnews.com - March 3 at 3:30 PM
Exactech, Inc. (EXAC) Shares Sold by Royce & Associates LPExactech, Inc. (EXAC) Shares Sold by Royce & Associates LP
www.americanbankingnews.com - March 3 at 9:12 AM
Water Island Capital LLC Acquires New Holdings in Exactech, Inc. (EXAC)Water Island Capital LLC Acquires New Holdings in Exactech, Inc. (EXAC)
www.americanbankingnews.com - March 2 at 9:38 PM
Spark Investment Management LLC Lowers Position in Exactech, Inc. (EXAC)Spark Investment Management LLC Lowers Position in Exactech, Inc. (EXAC)
www.americanbankingnews.com - March 1 at 6:50 PM
Exactech, Inc. (EXAC) Given Consensus Rating of "Hold" by BrokeragesExactech, Inc. (EXAC) Given Consensus Rating of "Hold" by Brokerages
www.americanbankingnews.com - February 27 at 9:30 PM
Harvest Management LLC Invests $3.23 Million in Exactech, Inc. (EXAC)Harvest Management LLC Invests $3.23 Million in Exactech, Inc. (EXAC)
www.americanbankingnews.com - February 27 at 3:00 PM
K2 Principal Fund L.P. Invests $5.02 Million in Exactech, Inc. (EXAC) StockK2 Principal Fund L.P. Invests $5.02 Million in Exactech, Inc. (EXAC) Stock
www.americanbankingnews.com - February 26 at 3:12 PM
With A -96.98% Earnings Drop Lately, Did Exactech Inc (NASDAQ:EXAC) Underperform Its Industry?With A -96.98% Earnings Drop Lately, Did Exactech Inc (NASDAQ:EXAC) Underperform Its Industry?
finance.yahoo.com - February 19 at 9:03 AM
BidaskClub Lowers Exactech (EXAC) to SellBidaskClub Lowers Exactech (EXAC) to Sell
www.americanbankingnews.com - February 17 at 11:00 PM
Exactech (EXAC) Gets Acquired by TPG Capital, Goes PrivateExactech (EXAC) Gets Acquired by TPG Capital, Goes Private
www.zacks.com - February 15 at 8:46 AM
Exactech Announces Completion of Merger with TPG CapitalExactech Announces Completion of Merger with TPG Capital
finance.yahoo.com - February 14 at 4:47 PM
Exactech (EXAC) Scheduled to Post Quarterly Earnings on MondayExactech (EXAC) Scheduled to Post Quarterly Earnings on Monday
www.americanbankingnews.com - February 12 at 3:02 AM
Critical Contrast: NuVasive (NUVA) versus Exactech (EXAC)Critical Contrast: NuVasive (NUVA) versus Exactech (EXAC)
www.americanbankingnews.com - February 12 at 1:16 AM
Exactech, Inc. (EXAC) Receives Consensus Recommendation of "Hold" from AnalystsExactech, Inc. (EXAC) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - February 2 at 9:24 PM
Exactech (EXAC) & Palomar Medical Technologies (PMTI) Critical AnalysisExactech (EXAC) & Palomar Medical Technologies (PMTI) Critical Analysis
www.americanbankingnews.com - January 29 at 1:12 AM
Osteon Merger Sub, Inc. -- Moodys assigns B2 Corporate Family Rating to acquirer of ExactechOsteon Merger Sub, Inc. -- Moody's assigns B2 Corporate Family Rating to acquirer of Exactech
finance.yahoo.com - January 25 at 9:08 AM
Exactech (EXAC) Cut to Sell at BidaskClubExactech (EXAC) Cut to Sell at BidaskClub
www.americanbankingnews.com - January 20 at 10:28 AM
The Europe Shoulder Arthroplasty Market would witness market growth of 7.5% CAGR during the forecast period (2017 - 2023)The Europe Shoulder Arthroplasty Market would witness market growth of 7.5% CAGR during the forecast period (2017 - 2023)
www.bizjournals.com - January 11 at 9:47 AM
Exactech, Inc. :EXAC-US: Earnings Analysis: Q3, 2017 By the Numbers : January 1, 2018Exactech, Inc. :EXAC-US: Earnings Analysis: Q3, 2017 By the Numbers : January 1, 2018
finance.yahoo.com - January 1 at 9:25 AM
The Global Shoulder Arthroplasty Market is expected to reach $ 1,866.3 million by 2023The Global Shoulder Arthroplasty Market is expected to reach $ 1,866.3 million by 2023
www.bizjournals.com - December 29 at 5:17 PM
LAWSUIT ALERT – Andrews & Springer LLC Announces That A Securities Class Action Has Been Filed Against Exactech, Inc. - EXACLAWSUIT ALERT – Andrews & Springer LLC Announces That A Securities Class Action Has Been Filed Against Exactech, Inc. - EXAC
finance.yahoo.com - December 28 at 3:03 PM
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning the Sale of Exactech, Inc. to TPC Capital is Fair to Shareholders - EXACSHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning the Sale of Exactech, Inc. to TPC Capital is Fair to Shareholders - EXAC
finance.yahoo.com - December 28 at 3:03 PM
Exactech (EXAC) Upgraded to "Hold" at Zacks Investment ResearchExactech (EXAC) Upgraded to "Hold" at Zacks Investment Research
www.americanbankingnews.com - December 26 at 9:52 PM
Comparing Zimmer Biomet (ZBH) and Exactech (EXAC)Comparing Zimmer Biomet (ZBH) and Exactech (EXAC)
www.americanbankingnews.com - December 24 at 12:40 AM
EXACTECH (EXAC) INVESTOR ALERT - Andrews & Springer LLC is Seeking More Cash for Shareholders of Exactech, Inc.EXACTECH (EXAC) INVESTOR ALERT - Andrews & Springer LLC is Seeking More Cash for Shareholders of Exactech, Inc.
finance.yahoo.com - December 21 at 9:28 AM
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Concerning the Sale of Exactech, Inc. to TPC Capital is Fair to Shareholders - EXACSHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Concerning the Sale of Exactech, Inc. to TPC Capital is Fair to Shareholders - EXAC
finance.yahoo.com - December 15 at 5:57 PM
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Exactech, Inc. (EXAC)SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Exactech, Inc. (EXAC)
www.prnewswire.com - December 15 at 10:33 AM
Exactech, Inc. (EXAC) Given Consensus Rating of "Hold" by AnalystsExactech, Inc. (EXAC) Given Consensus Rating of "Hold" by Analysts
www.americanbankingnews.com - December 14 at 11:32 PM
EXACTECH (EXAC) SHAREHOLDER ALERT - Andrews & Springer LLC is Seeking More Cash for Shareholders of Exactech, Inc.EXACTECH (EXAC) SHAREHOLDER ALERT - Andrews & Springer LLC is Seeking More Cash for Shareholders of Exactech, Inc.
finance.yahoo.com - December 14 at 9:35 AM
EXACTECH MERGER INVESTIGATION ALERT - Andrews & Springer LLC Is Seeking More Cash for Shareholders of Exactech, Inc.EXACTECH MERGER INVESTIGATION ALERT - Andrews & Springer LLC Is Seeking More Cash for Shareholders of Exactech, Inc.
feeds.benzinga.com - December 13 at 8:33 PM
ETFs with exposure to Exactech, Inc. : December 7, 2017ETFs with exposure to Exactech, Inc. : December 7, 2017
finance.yahoo.com - December 7 at 5:48 PM
Exactech Announces Successful First Surgery with Vantage ® Total Ankle Mobile Bearing SystemExactech Announces Successful First Surgery with Vantage ® Total Ankle Mobile Bearing System
finance.yahoo.com - December 7 at 5:48 PM
Exactechs (EXAC) Hold Rating Reaffirmed at Robert W. BairdExactech's (EXAC) Hold Rating Reaffirmed at Robert W. Baird
www.americanbankingnews.com - December 7 at 7:56 AM
Wall Streets M&A Chatter From December 4: Prysmian-General Cable, Exactech-TPG Capital, TTM Technologies-AnarenWall Street's M&A Chatter From December 4: Prysmian-General Cable, Exactech-TPG Capital, TTM Technologies-Anaren
www.benzinga.com - December 5 at 10:09 AM
Exactech (EXAC), TPG Capital Amend Merger Agreement Providing for Increase in Consideration to $49.25/ShareExactech (EXAC), TPG Capital Amend Merger Agreement Providing for Increase in Consideration to $49.25/Share
www.streetinsider.com - December 5 at 10:09 AM
BRIEF-Exactech And TPG Capital Announce Amended Merger Agreement With Increase In Merger Consideration To $49.25 Per ShareBRIEF-Exactech And TPG Capital Announce Amended Merger Agreement With Increase In Merger Consideration To $49.25 Per Share
www.businessinsider.com - December 5 at 10:09 AM
Exactech Inc. (EXAC) Jumped To A New High After Amended Merger AgreementExactech Inc. (EXAC) Jumped To A New High After Amended Merger Agreement
www.rttnews.com - December 5 at 10:09 AM
Exactech gets higher $737 million cash offer from TPG CapitalExactech gets higher $737 million cash offer from TPG Capital
www.reuters.com - December 5 at 10:09 AM
ACT NOW: Monteverde & Associates PC Announces An Investigation Of Exactech, Inc. - EXACACT NOW: Monteverde & Associates PC Announces An Investigation Of Exactech, Inc. - EXAC
finance.yahoo.com - December 4 at 5:20 PM

SEC Filings

Exactech (NASDAQ:EXAC) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Exactech (NASDAQ:EXAC) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Exactech (NASDAQ EXAC) Stock Chart for Thursday, April, 26, 2018

Loading chart…

This page was last updated on 4/26/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.